SMOKING CESSATION
Clinical trials for SMOKING CESSATION explained in plain language.
Never miss a new study
Get alerted when new SMOKING CESSATION trials appear
Sign up with your email to follow new studies for SMOKING CESSATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Quit smoking before surgery to cut complications, study suggests
Disease control TerminatedThis study looked at whether a structured smoking cessation program, started four weeks before surgery, could reduce complications in smokers undergoing intermediate to high-risk operations. Researchers planned to enroll 251 adults who smoked daily and were scheduled for surgerie…
Matched conditions: SMOKING CESSATION
Phase: NA • Sponsor: Luzerner Kantonsspital • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Could a drug combo help smokers with schizophrenia quit?
Symptom relief TerminatedThis small early-stage study tested whether a combination of two medicines—an injectable drug called naltrexone and a daily pill called bupropion—could help people with schizophrenia who smoke cigarettes to quit or reduce smoking. The study aimed to see if the treatment was safe …
Matched conditions: SMOKING CESSATION
Phase: PHASE1 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated May 17, 2026 00:40 UTC
-
Brain zaps may help smokers with schizophrenia quit
Knowledge-focused TerminatedThis study tested whether deep brain stimulation (dTMS) could help people with schizophrenia smoke less. Researchers used brain scans to see how the treatment changed brain connections and smoking habits. The study was small and ended early, so results are limited.
Matched conditions: SMOKING CESSATION
Phase: NA • Sponsor: Stony Brook University • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC